QN NERVOUS SYSTEM
QN04 ANTI-PARKINSON DRUGS
QN04B DOPAMINERGIC AGENTS
QN04BD Monoamine oxidase B inhibitors
QN04BD01 selegiline
QN04BD02 rasagiline
QN04BD03 safinamide
Last updated: 2022-12-22
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer